Kim DW - Search Results

1

Multinational Randomized Phase III Trial With or Without Consolidation Chemotherapy Using Docetaxel and Cisplatin After Concurrent Chemoradiation in Inoperable Stage III Non-Small-Cell Lung Cancer: KCSG-LU05-04.

Ahn JS, Ahn YC, Kim JH, Lee CG, Cho EK, Lee KC, Chen M, Kim DW, Kim HK, Min YJ, Kang JH, Choi JH, Kim SW, Zhu G, Wu YL, Kim SR, Lee KH, Song HS, Choi YL, Sun JM, Jung SH, Ahn MJ, Park K. Ahn JS, et al. Among authors: kim sr, kim dw, kim hk, kim sw, kim jh. J Clin Oncol. 2015 Aug 20;33(24):2660-6. doi: 10.1200/JCO.2014.60.0130. Epub 2015 Jul 6. J Clin Oncol. 2015. PMID: 26150444 Clinical Trial.

2

Comparison of intrathecal chemotherapy for leptomeningeal carcinomatosis of a solid tumor: methotrexate alone versus methotrexate in combination with cytosine arabinoside and hydrocortisone.

Kim DY, Lee KW, Yun T, Park SR, Jung JY, Kim DW, Kim TY, Heo DS, Bang YJ, Kim NK. Kim DY, et al. Among authors: kim dw, kim ty, kim nk. Jpn J Clin Oncol. 2003 Dec;33(12):608-12. doi: 10.1093/jjco/hyg118. Jpn J Clin Oncol. 2003. PMID: 14769837

3

Epidermal growth factor receptor (EGFR) downstream molecules as response predictive markers for gefitinib (Iressa, ZD1839) in chemotherapy-resistant non-small cell lung cancer.

Han SW, Hwang PG, Chung DH, Kim DW, Im SA, Kim YT, Kim TY, Heo DS, Bang YJ, Kim NK. Han SW, et al. Among authors: kim dw, kim ty, kim yt, kim nk. Int J Cancer. 2005 Jan 1;113(1):109-15. doi: 10.1002/ijc.20550. Int J Cancer. 2005. PMID: 15386420 Free article. Clinical Trial.

4

Neoadjuvant etoposide, ifosfamide, and cisplatin for the treatment of olfactory neuroblastoma.

Kim DW, Jo YH, Kim JH, Wu HG, Rhee CS, Lee CH, Kim TY, Heo DS, Bang YJ, Kim NK. Kim DW, et al. Among authors: kim ty, kim nk, kim jh. Cancer. 2004 Nov 15;101(10):2257-60. doi: 10.1002/cncr.20648. Cancer. 2004. PMID: 15484215 Free article.

5

A multi-center, late phase II clinical trial of Genexol (paclitaxel) and cisplatin for patients with advanced gastric cancer.

Park SR, Oh DY, Kim DW, Kim TY, Heo DS, Bang YJ, Kim NK, Kang WK, Kim HT, Im SA, Suh JH, Kim HK, Kim HK. Park SR, et al. Among authors: kim dw, kim hk, kim ty, kim ht, kim nk. Oncol Rep. 2004 Nov;12(5):1059-64. Oncol Rep. 2004. PMID: 15492793 Clinical Trial.

6

Paclitaxel/Platinum-based perioperative chemotherapy and surgery in stage IIIA non-small cell lung cancer.

Choi IS, Oh DY, Kwon JH, Kim SI, Park SR, Bak JY, Kim JH, Kim DW, Kim YT, Kim TY, You CK, Kim YW, Heo DS, Bang YJ, Sung SW, Park CI, Kim NK. Choi IS, et al. Among authors: kim dw, kim ty, kim si, kim yt, kim nk, kim jh, kim yw. Jpn J Clin Oncol. 2005 Jan;35(1):6-12. doi: 10.1093/jjco/hyi008. Jpn J Clin Oncol. 2005. PMID: 15681597

7

Predictive and prognostic impact of epidermal growth factor receptor mutation in non-small-cell lung cancer patients treated with gefitinib.

Han SW, Kim TY, Hwang PG, Jeong S, Kim J, Choi IS, Oh DY, Kim JH, Kim DW, Chung DH, Im SA, Kim YT, Lee JS, Heo DS, Bang YJ, Kim NK. Han SW, et al. Among authors: kim dw, kim ty, kim j, kim yt, kim nk, kim jh. J Clin Oncol. 2005 Apr 10;23(11):2493-501. doi: 10.1200/JCO.2005.01.388. Epub 2005 Feb 14. J Clin Oncol. 2005. PMID: 15710947 Clinical Trial.

8

Efficacy of platinum-based chemotherapy after cranial radiation in patients with brain metastasis from non-small cell lung cancer.

Kim DY, Lee KW, Yun T, Kim DW, Kim TY, Heo DS, Bang YJ, Kim NK. Kim DY, et al. Among authors: kim dw, kim ty, kim nk. Oncol Rep. 2005 Jul;14(1):207-11. Oncol Rep. 2005. PMID: 15944791 Clinical Trial.

9

Docetaxel + 5-fluorouracil + cisplatin 3-day combination chemotherapy as a first-line treatment in patients with unresectable gastric cancer.

Oh DY, Kim TY, Kwon JH, Lee JJ, Joh Y, Kim DW, Kim TY, Heo DS, Bang YJ, Kim NK. Oh DY, et al. Among authors: kim dw, kim ty, kim nk. Jpn J Clin Oncol. 2005 Jul;35(7):380-5. doi: 10.1093/jjco/hyi107. Epub 2005 Jun 23. Jpn J Clin Oncol. 2005. PMID: 15976069 Clinical Trial.

10

Optimization of patient selection for gefitinib in non-small cell lung cancer by combined analysis of epidermal growth factor receptor mutation, K-ras mutation, and Akt phosphorylation.

Han SW, Kim TY, Jeon YK, Hwang PG, Im SA, Lee KH, Kim JH, Kim DW, Heo DS, Kim NK, Chung DH, Bang YJ. Han SW, et al. Among authors: kim dw, kim ty, kim nk, kim jh. Clin Cancer Res. 2006 Apr 15;12(8):2538-44. doi: 10.1158/1078-0432.CCR-05-2845. Clin Cancer Res. 2006. PMID: 16638863

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

5,166 results

Search Page